Intravascular ultrasound analysis of beta radiation therapy for diffuse in-stent restenosis to inhibit intimal hyperplasia

Catheter Cardiovasc Interv. 2001 Oct;54(2):169-73. doi: 10.1002/ccd.1261.

Abstract

We evaluated the efficacy of beta-radiation therapy ((188)Re-MAG(3)) to inhibit intimal hyperplasia (IH) in diffuse in-stent restenosis by intravascular ultrasound (IVUS) analysis in 50 patients. Nine patients who did not agree with radiation therapy, and therefore underwent rotational atherectomy and balloon angioplasty for diffuse in-stent restenosis in the same study period, were selected for control groups. Serial IVUS comparisons were available in 44 of 50 patients with radiation therapy and 7 of 9 control patients. At 6-month follow-up, there was less significant increase of IH area in patients with radiation therapy than in control patients (Delta IH area = 0.1 +/- 0.8 mm(2) vs. 2.6 +/- 1.8 mm(2), P > 0.001 in mean values, and 0.6 +/- 1.4 mm(2) vs. 2.9 +/- 2.1 mm(2), P = 0.026 in values of follow-up lesion site, respectively). In conclusion, beta-radiation therapy might be an effective treatment modality to inhibit intimal hyperplasia in patients with diffuse in-stent restenosis.

Publication types

  • Clinical Trial
  • Controlled Clinical Trial
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Aged
  • Angioplasty, Balloon, Coronary*
  • Atherectomy, Coronary
  • Beta Particles / therapeutic use
  • Coronary Angiography
  • Female
  • Follow-Up Studies
  • Graft Occlusion, Vascular / diagnostic imaging*
  • Graft Occlusion, Vascular / therapy*
  • Humans
  • Hyperplasia / diagnostic imaging
  • Hyperplasia / radiotherapy
  • Male
  • Middle Aged
  • Tunica Intima / diagnostic imaging*
  • Tunica Intima / pathology*
  • Ultrasonography, Interventional*